Fatty liver disease, especially a type called non-alcoholic fatty liver disease (NAFLD), is becoming a serious health problem across the world. It affects about one in four people, yet many don’t even know they have it.
That’s because in the early stages, it usually doesn’t cause any symptoms. But if it’s not treated, it can lead to serious conditions like type 2 diabetes, heart disease, liver damage, and even liver cancer.
At the moment, the only way to slow down or stop NAFLD is by changing your lifestyle. That means eating fewer calories, losing weight, and exercising regularly. But even these changes work best only in the early stages.
Once the disease gets worse and turns into a more serious form known as NASH (non-alcoholic steatohepatitis), there’s no medicine available to treat it. That’s why scientists around the world are working hard to find new treatments.
A group of researchers in China, led by Mengyao Wu from Guangzhou University, may have made a major breakthrough. They’ve been studying a special molecule in the liver called Adgrf1. This molecule is mostly found in liver cells.
When researchers fed mice a high-fat diet to mimic the early stages of fatty liver disease, they found that the amount of Adgrf1 in the liver dropped a lot. This could mean that lower levels of Adgrf1 are an early warning sign of the disease.
The team didn’t stop there. They tested what happens when they changed the levels of Adgrf1 in mice. When they reduced the molecule, the mice began to show signs of diabetes. Their blood sugar and insulin levels went up, which suggests that Adgrf1 is also important for controlling how the body handles fat and sugar.
Then, they tried something even more exciting. They used a method to block Adgrf1 in mice that already had fatty liver disease. The result? Their liver health improved. This means that stopping or reducing Adgrf1 could actually help treat the disease, not just prevent it.
To make sure this finding wasn’t just true for mice, the scientists looked at liver samples from human patients with different levels of NAFLD. What they found matched their mouse experiments: people with more serious fatty liver disease had higher levels of Adgrf1.
This discovery could be a big step forward. Because Adgrf1 is found mostly in the liver, creating a drug that targets it might help avoid side effects in other parts of the body. If future research confirms how this molecule works and how to safely target it, scientists might be able to create a new treatment for a disease that currently has no medicine.
The study was published in the journal eLife. While it’s still early days, this research gives new hope to millions of people around the world. For now, taking care of your liver through diet and exercise is still the best way to protect it.
Some recent studies suggest that drinking coffee or eating dairy foods may help lower the risk of liver cancer. Others show that an anti-inflammatory diet or getting enough vitamin D could help prevent NAFLD.
It’s clear that scientists are working hard to better understand liver health. And thanks to this latest study, a real treatment for fatty liver disease might be on the horizon.
If you care about liver health, please read studies about a diet that can treat fatty liver disease and obesity, and coffee drinkers may halve their risk of liver cancer.
For more information about liver health, please see recent studies that anti-inflammatory diet could help prevent fatty liver disease, and results showing vitamin D could help prevent non-alcoholic fatty liver disease.
Copyright © 2025 Knowridge Science Report. All rights reserved.
